/
AGN.AX
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Argenica Therapeutics Ltd
Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia.
argenica.com.au- Employees
- 7
- IPO / List date
- Jun 11, 2021
- HQ
- AU
Held by traders on TradeandTell
No one on the platform currently holds AGN.AX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AGN.AX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded AGN.AX yet.